|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable and accrued revenue | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Assets of consolidated investment products ($1,906.6 million at June 30, 2026 and $1,596.1 million at June 30, 2025, related to variable interest entities) | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Property, equipment and software, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Liabilities of consolidated investment products ($98.0 million at March 31, 2026 and $14.2 million at March 31, 2025, related to variable interest entities) | ||||||||||||||||||||
| Liabilities of consolidated investment products ($414.6 million at June 30, 2026 and $14.2 million at June 30, 2025, related to variable interest entities) | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued compensation and related costs | ||||||||||||||||||||
| Deferred compensation liabilities | ||||||||||||||||||||
| Contingent consideration liability | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable non-controlling interests | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred stock, undesignated, $0.20 par value — authorized and unissued 20,000,000 shares | ||||||||||||||||||||
| Common stock, $0.20 par value — authorized 750,000,000; issued 213,312,000 shares at June 30, 2026 and 218,565,000 at December 31, 2025 | ||||||||||||||||||||
| Additional capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity attributable to T. Rowe Price Group | ||||||||||||||||||||
| Non-controlling interests in consolidated entities | ||||||||||||||||||||
| Total permanent stockholders' equity | ||||||||||||||||||||
| Total liabilities, redeemable non-controlling interests, and permanent stockholders' equity |
Loading...
